SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001961863-24-000219
Filing Date
2024-07-09
Accepted
2024-07-09 16:18:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5481
  Complete submission text file 0001961863-24-000219.txt   7178
Mailing Address 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Opportunity Fund I, L.P. (Reporting) CIK: 0001759241 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Subject) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39460 | Film No.: 241107659
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)